Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;8(1):97-100.

Cystatin C in sera of patients with aggressive non-Hodgkin B-cell lymphoma

Adaleta Softić  1 , Lejla Begić, Alma Halilbasić, Janko Kos
Affiliations
  • PMID: 21263405

Cystatin C in sera of patients with aggressive non-Hodgkin B-cell lymphoma

Adaleta Softić et al. Med Glas (Zenica). 2011 Feb.

Abstract

Aim: To investigate the cystatin C levels in sera of patients with aggressive non-Hodgkin B-cell lymphoma.

Methods: The levels of cystatin C in sera of lymphoma patients and control group consisted of healthy individuals, were measured by using specific sandwich-type ELISA. For each patient the clinical stage of disease was determined according to Ann Arbor staging system for lymphomas.

Results: Our study shows that mean cystatin C serum level in the patients group (1056 +/- 65 ng/mL) was significantly higher when compared with the mean level of the healthy control group (819 +/- 28 ng/mL) (P = 0.001). Mean cystatin C level of the group with clinical stages III and IV (1255 +/- 109 ng/mL) was significantly elevated when compared with the mean level of the group with clinical stages I and II (896 +/- 51 ng/mL) (P = 0.03).

Conclusion: This finding points out a connection between inhibitor level and aggressive behaviour of lymphoma and could be considered for further strategies of prognosis of the disease.

PubMed Disclaimer

Publication types